Sir, Dexamethasone implant in diabetic macular edema
We thank Gupta and Ram 1 for their interest in our publication 2 on dexamethasone implant in diabetic macular edema (DME). Because of the retrospective nature of the study, we could not get the complete information on systemic factors such as hypertension and lipid profile. However, recently, Singh et al reported that the vision outcome with ranibizumab in DME was not influenced by systemic factors such as diabetes medication history, serum glucose, HbA1c, renal function, and blood pressure in the RIDE and RISE phase 3 studies. 3 Seven eyes underwent panretinal photocoagulation (PRP) during the follow-up. We agree with the authors that there could be slight increase in the macular edema after PRP and may have affected the final outcome. Interestingly, a recent prospective study by Lee et al 4 showed no effect on visual acuity of PRP at 12 months irrespective of persistent macular edema.
We thank the authors once again for this interesting discussion.
